Connect Biopharma Holdings Limited
CNTB
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$2.77
FAIR PRICE
$1.37
MARGIN
$1.40
P/E Ratio
N/A
Div. Yield
N/A
ROE
N/A
Market Cap
$146M
Small-cap
COMING SOON
Get notified when CNTB's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Barry D. Quart
COUNTRY
CN
HEADQUARTERS
Taicang
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate CNTB's fair price
Connect Biopharma Holdings Limited's fair price of $1.37 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $2.77, CNTB trades 50.5% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting CNTB's risk profile.
RELATIVE · 30%
Comparing CNTB's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for CNTB, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate CNTB's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for CNTB.
Explore on BuliosFAQ
What is the fair price of CNTB?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Connect Biopharma Holdings Limited is $1.37. At the current market price of $2.77, CNTB trades 50.5% above its calculated fair value.
Is CNTB overvalued or undervalued?+
Connect Biopharma Holdings Limited is currently overvalued based on our valuation model. The stock trades at $2.77, which is 50.5% above the fair price of $1.37.
How often is CNTB's fair price updated?+
We update fair price calculations for CNTB daily after market close. The current fair price of $1.37 incorporates the latest market data and sector multiples.
What factors affect CNTB's fair price calculation?+
CNTB's fair price of $1.37 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)..
Is CNTB a good buy right now?+
At $2.77, CNTB trades 50.5% above our fair value estimate of $1.37. The stock is currently overvalued. Fair Price Index provides valuation data — always do your own research before investing.
Does CNTB pay dividends?+
CNTB does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.